Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA0SN
|
||||
| Drug Name |
(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-10-vinyl-1,7,8,10,11,12,13,15,16,17-decahydro-2H-cyclopenta[a]phenanthren-3(6H,9H,14H)-one
|
||||
| Synonyms |
CHEMBL246140
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H28O2
|
||||
| Canonical SMILES |
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C=C)[C@@H]1CC[C@@H]2O
|
||||
| InChI |
InChI=1S/C20H28O2/c1-3-20-11-8-14(21)12-13(20)4-5-15-16-6-7-18(22)19(16,2)10-9-17(15)20/h3,12,15-18,22H,1,4-11H2,2H3/t15-,16-,17-,18-,19-,20-/m0/s1
|
||||
| InChIKey |
QIMSMVYRWNZWBL-RABCQHRBSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | [1587926] | ||
| mRNA of androgen receptor | Target Info | [1587926] | |||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
| Validated nuclear estrogen receptor beta network | |||||
| Validated nuclear estrogen receptor alpha networksmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | |||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.